Immunocore (IMCR) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Immunocore

NASDAQ: IMCR · Real-Time Price · USD
34.21
-1.07 (-3.05%)
At close: Oct 03, 2025, 3:59 PM
34.00
-0.61%
After-hours: Oct 03, 2025, 04:37 PM EDT

Immunocore Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-10.3M 5.02M -23.55M 8.74M -11.62M -24.44M -33.39M 2.32M -17.83M -20.64M -25.2M 6.23M -6.12M -16.13M -39.39M -30.13M -32.96M -29.04M
Depreciation & Amortization
780K 854K 1.17M 1.03M 992K 1.01M 152.94K 1.66M 1.67M 1.59M 1.34M 1.48M 1.64M 1.68M 1.72M 1.71M 1.77M 1.81M
Stock-Based Compensation
10.03M 9.49M 8.67M 6.56M 10M 8.96M 15.29M 8.17M 6.83M 10.21M 6.87M 6.09M 6.67M 7.41M 8.72M 9.2M 9.34M 8.6M
Other Working Capital
37.84M -11.79M -12.84M -32.4M 25.43M 16.66M 26.92M 7.13M 10.48M -65.51K 12.69M 11.6M -621K -24.41M -1.35M -2.13M -8.97M -4.35M
Other Non-Cash Items
-1.28M -7.32M 8.01M 40.16M -3.13M 1.73M 4.53M -11.26M 1.73M 17.93M 15.28M -10.99M -10.76M 2.27M 13.76M 2.27M 1.03M 1.69M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 2.21M -175.15K 191.22K 291.71K 2.13M -1.24M -2.15M -1.66M 214K -2.13M -2.81M -4.68M
Change in Working Capital
26.74M -7.61M -8.25M -35.36M 27.22M 8.14M -5.72M 5.51M 2.36M 3.46M 5.62M 6.53M -621K -24.41M -1.35M -2.13M -8.97M -4.35M
Operating Cash Flow
25.96M 435K -13.95M 21.13M 23.47M -4.59M -16.92M 6.23M -3.03M 10.87M 6.03M 8.09M -9.18M -30.83M -16.33M -21.2M -32.6M -25.98M
Capital Expenditures
-414K -298K -3.58M -828K -331K -430K -595.34K -2.09M -972.54K -3.05M -1.33M -394K -337K -138K -278K -374K -136K -220K
Cash Acquisitions
n/a n/a 44.02K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-30M n/a n/a 109.68K -350.11M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a 10M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -18 -109.68K 109.68K n/a 1.36M 4.69M 4.4M 2.57M 1.66M 597K 128K 5K 13K 228K 155K 245K
Investing Cash Flow
-30.41M 9.7M -3.54M -828K -350.33M -430K 766.13K 2.6M 3.43M -487.01K 332K 203K -209K -133K -265K -146K 19K 25K
Debt Repayment
n/a n/a -402.5M 1.63M -771.21K 402.5M 1.36M n/a n/a n/a -1.35M -816K -694K -755K -953.76K -864K -799K -802K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-43.68K -9.79K 350.46M -1.65M -349.97K -12.24M 37.84K -2.78M 9.32M 6.14M -4.52M 1.52M 156K -577K -2.68M -206K -813K -16.35M
Financial Cash Flow
3.67M 2.55M -51.51M 198K -818K 396.01M 7.72M 7.81M 9.32M 3.07M -1.19M 117.52M -538K -1.33M -2.06M -1.07M -1.61M 209.37M
Net Cash Flow
11.09M 21.11M -82.04M 32.78M -327.84M 390.19M -1.6M 26.29M 6.18M 6.08M -14.65M 139.13M 2.21M -32.03M -18.66M -22.32M -34.21M 183.37M
Free Cash Flow
25.55M 137K -17.54M 20.3M 23.14M -5.02M -11.44M 4.14M -4M 7.81M 4.7M 7.7M -9.52M -30.97M -16.61M -21.58M -32.73M -26.2M